IUC26597-94

Abstract Code: IUC26597-94   Longitudinal Trends in Androgen Receptor Pathway Inhibitor Prescribing for Metastatic Prostate Cancer in England Between 2013-2025 Using Real-World Data from the NHS England Prior Approval System J.K.H. Liu 1, A. Cook 1, J. Dodkins 1,...

IUC26567-91

Abstract Code: IUC26567-91   A Novel, Cost-Reducing Hyaluronic Acid and Lipiodol Composite for Perirectal Tissue Spacing in Prostate Cancer: Safety and efficacy S. Elgarhy 1, A.G. El-Gowily 2, M.M. Elshafei 3, E. Elalfy 4, Y. Elsaid 3, A. Eldrieny 5, D. Salama 6,...

IUC26557-90

Abstract Code: IUC26557-90   Retrospective Review of a Prostate Brachytherapy Case cohort Conducted in  Botswana: Clinical Outcomes and Adverse Events A. Bunga 1, B. Molatodi 2, R. Tapera 3, P. Vuylsteke 3 (1) Juliant Medical Investments, Gaborone –...

IUC25511-79

Abstract Code: IUC25511-79 Prostate volume changes during longer fractionated and ultra-hypofractionated MR-guided adaptive radiotherapy leveraging the MOMENTUM registry S. Cooper 1, H. Akhiat 2, S. Alexander 1, F. Alongi 3, E. Blezer 4, A. Choudhury 5, J....

IUC26660-85

Abstract Code: IUC26660-85   Severe immune checkpoint inhibitor toxicity drives additional costs M. Khanjra 1, M. Emmerich 2, J. Larkin 1, Z. Tippu 1, S. Turajlic 3 (1) Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London – United Kingdom,...

IUC25592-88

Abstract Code: IUC25592-88   Exploring the Use of AI-Enhanced Virtual Reality in Teaching and Evaluating Communication Skills in Urology: A Pilot Study M. Saad 1 (1) Newham University Hospital – United Kingdom   Exploring the Use of AI-Enhanced Virtual...
error: Content is protected !!